Key Points
India's drug regulator has proposed testing cough syrups in government laboratories before they are exported, media report said on Tuesday, after Indian-made syrups were linked to dozens of deaths in Gambia and Uzbekistan last year...
India's health ministry received the proposal from the Central Drugs Standard Control Organisation(CDSCO) this month and is considering it, the news website quoted an unidentified ministry official as saying...
"The proposal is to test the finished goods at government labs before exporting," the official told the news website...
India's $41 billion pharmaceutical industry received a major jolt last year when cough syrups made by two companies based near New Delhi were linked to the deaths of at least 70 children in Gambia and 19 in Uzbekistan...
The World Health Organization said last year that Indian manufacturer Maiden Pharmaceuticals Ltd's syrups, exported to Gambia, contained lethal toxins ethylene glycol (EG) and diethylene glycol (DEG) - used in car brake fluid...
You might be interested in
India makes cough syrup testing mandatory for exports
23, May, 23The move comes after some Indian cough syrups were linked to deaths in The Gambia and Uzbekistan.
Desi pharma pangs continue for India despite dose to fortify pharmacy of the world tag
16, Nov, 23India, once the 'pharmacy of the world', is struggling to establish itself as an elite player due to poor manufacturing practices that have led to deaths in some parts of the world, including children. The deaths of children in the West African nation of Gambia in 2022 and the deaths of 65 children in Uzbekistan last year have highlighted the lapse in the quality of drug production in certain India-based pharmaceuticals.
Probe into bribery claim linked to 'fatal' cough syrup in final stages: Report
22, Dec, 23Authorities were investigating claims that a state drug regulator substituted samples of an India-made cough syrup linked to child deaths in the Gambia before they could undergo testing.
Uzbek cough syrup deaths: DCGI issues alert against supplier of Marion Biotech
10, Mar, 23A representative of Maya Chemtech, who spoke on condition of anonymity, said the company did not sell the raw material to Marion for pharmaceutical products, but cosmetics. | Latest News Delhi
India drugs regulator orders quality checks on cough syrup ingredient
08, Dec, 23India's drugs regulator has ordered that the source and quality of an ingredient used to make cough syrups be checked and verified as a "top priority", in the wake of the deaths of at least 141 children globally.
Exclusive: Gambia families sue Indian drugmaker after cough syrup deaths
30, Jun, 23The relatives of 20 Gambian children whose deaths were linked to toxic cough syrups made in India have sued Indian drugmaker Maiden Pharmaceuticals as well as local authorities in the West African country, according to a case filed on Friday and seen by Reuters.
Exclusive: India allows cough syrup firm linked to Uzbek deaths to re-open factory
11, Oct, 23India's northern state of Uttar Pradesh has permitted the resumption of most production at a factory owned by Marion Biotech, which produced cough syrups Uzbekistan linked to the deaths of 65 children last year, an order seen by Reuters shows.
U.S.-CDC probe into cough syrup deaths in The Gambia pins blame on Indian manufacturer
03, Mar, 23The report says investigation strongly suggests that medications contaminated with Diethylene Glycol or Ethylene Glycol imported into The Gambia led to this Acute Kidney Injury cluster among children
India mandates new drug manufacturing standards after multiple overseas deaths
06, Jan, 24WHO and other health authorities had linked Indian cough syrups to the deaths of at least 141 children in Gambia, Uzbekistan and Cameroon.
India's drugs regulator bans anti-cold drug for children aged under four
21, Dec, 23India's drug regulator has banned anti-cold drug combination for kids under four, responding to global concerns after at least 141 deaths linked to cough syrups | Health